Bisphenol A

As an important organic chemical raw material, bisphenol A is a phenol acetone derivative produced through condensation reaction. It is the core monomer for the production of polycarbonate, epoxy resin, thermal paper and other materials, with downstream applications covering food packaging, medical devices, electronic and electrical appliances, building materials and many other fields. In medical scenarios, polycarbonate derived from bisphenol A is widely used in the manufacture of consumables such as infusion containers, surgical device shells, and medical protective face shields due to its excellent light transmittance, impact resistance and temperature resistance, and is an indispensable basic chemical raw material in the upstream of the medical supply chain.

The global bisphenol A market size has exceeded USD 23 billion in 2023, and the compound annual growth rate from 2024 to 2030 is expected to remain around 4.8%. The demand increment mainly comes from new energy, high-end medical devices and electronic packaging fields. The current market supply is dominated by East Asia, with China's production capacity accounting for more than 60% of the global total production capacity. The industry concentration is relatively high, with the top 10 enterprises accounting for 85% of the domestic total production capacity. Overcapacity of low-end products coexists with supply gaps of high-end food-grade and medical-grade products. The purity requirement for medical-grade bisphenol A is above 99.95%, with relatively high technical barriers.

As a bulk chemical raw material, bisphenol A has no specific original research enterprise. The global mainstream production process is ionic bisphenol A technology. At present, there are many mature manufacturers at home and abroad supplying industrial-grade, food-grade and medical-grade products. There are 12 registered drug substance-grade bisphenol A related registration numbers in China, among which 7 are in A status, which can be associated with preparations for use. The supporting medical polycarbonate, medical epoxy resin preparations and consumables have all achieved localized supply. (Data as of April 2025, please refer to the official website of CDE for the latest information)

CATO provides a full set of bisphenol A impurity reference standards, which meet the compliance requirements of multiple regulations such as the Chinese Pharmacopoeia and FDA. Most products are in stock. For in-stock products, orders placed before 16:00 can be shipped on the same day, which can fully meet the needs of quality research, registration and declaration, and daily testing of API and downstream medical consumable enterprises.